secwatch.observer — SEC 8-K summary
======================================

Issuer:     Estrella Immunopharma, Inc. (ESLA)
CIK:        0001844417
Form:       8-K
Filed at:   2023-04-05T23:59:59+00:00
Accession:  0001575872-23-000519
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

TradeUP Acquisition Corp. receives Nasdaq delisting notice for MVLS below $35M
------------------------------------------------------------------------------

- Nasdaq notified TradeUP on April 3, 2023 that its Market Value of Listed Securities (MVLS) was below $35M for 30 consecutive business days.
- The deficiency is under Nasdaq Listing Rule 5550(b)(2); the notice does not trigger immediate delisting.
- Company has 180 days, until October 2, 2023, to regain compliance by achieving MVLS of at least $35M for 10 consecutive business days.
- Failure to cure by the deadline will result in a delisting notice; the company may appeal any such determination.
- TradeUP is evaluating options to regain compliance, but there is no assurance of success.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844417/000157587223000519/0001575872-23-000519-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844417/000157587223000519/uptd-20230303.htm
  HTML page:      https://secwatch.observer/filing/0001575872-23-000519

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer